Elsevier Expands Use of CCC's RightsLink® Service; Customers Now Able to Order Reprints Online
Copyright Clearance Center

Elsevier Expands Use of CCC's RightsLink® Service;
Customers Now Able to Order Reprints Online

DANVERS, Mass., July 29, 2008—Elsevier, the world's leading publisher of scientific, technical and medical information products and services, is about to make it even easier for readers and subscribers to its more than 2,800 online journals to purchase article reprints for a variety of uses. Elsevier is partnering with Copyright Clearance Center to use CCC's RightsLink® service, the world's leading online platform for marketing and monetizing the rights to content.

The new reprint-ordering capability, available now, follows Elsevier's initial adoption of RightsLink in 2007 to handle copyright permissions for Elsevier's journals. RightsLink is an online e-commerce service that allows content users to instantly license content and order reprints online. The most widely used web-based licensing application, RightsLink is in use on more than 11,000 journals, magazines and newspapers, as well as thousands of books online. Customers have used RightsLink to place tens of millions of dollars in licenses, permissions and reprints. In addition, RightsLink's real-time reporting capabilities provide publishers with a comprehensive view of licensing and reprint activity.

More major publishers around the world use RightsLink than any service of its kind. They include: Dow Jones, The New York Times Company, Springer, Taylor & Francis, O'Reilly Media, Time Inc., Oxford University Press, Nature Publishing Group, The University of Chicago Press, Blackwell Publishing and USA Today.

"We're already using RightsLink to automate copyright permissions across a wide range of Elsevier content and the service has performed exceptionally well while getting very positive feedback from our customers," said Luis Portero, Elsevier's Vice President of Commercial Sales, U.S. Journals. "Now RightsLink lets our journal readers efficiently order reprints directly from ScienceDirect content pages online, providing a fast and easy transaction. It is also integrated into our print-and-delivery business process, giving us enhanced global operational efficiencies."

ScienceDirect and Elsevier's Health Sciences platforms deliver more than 9 million articles online from more than 2,500 peer-reviewed journals published in 24 fields of science, technology and medicine. More than 1 billion articles have been downloaded from the ScienceDirect and Health Sciences platforms by scientists, teachers and researchers.

"We can now deliver an increased service level to our customers, letting them conveniently order reprints directly from ScienceDirect and Health Sciences articles at any time, anywhere in the world," said Kate Alzapiedi, Elsevier's Commercial Sales Director, Science & Technology Journals.

"We are delighted to see Elsevier continue to expand its use of RightsLink," said Tracey Armstrong, CEO and President of CCC. "Elsevier is a world-class publisher that constantly seeks new ways to enhance customer service, improve operations and grow revenue. RightsLink supports all three goals."

About Copyright Clearance Center
Copyright Clearance Center, which is celebrating its 30th anniversary, creates innovative licensing solutions for the seamless sharing of knowledge. CCC's licensing services, combined with its Web-based applications and tools, allow tens of millions of people in corporations, universities, law firms and government agencies to use and share published information with ease. Since its founding as a not-for-profit company in 1978, CCC has created and expanded the markets and systems that facilitate content reuse and the distribution of royalties to publishers and authors around the world. By offering rights to millions of the world's most sought-after publications, the company plays a major role in the global knowledge economy and encourages support for the principles of copyright. For more information please visit www.copyright.com.

About ScienceDirect
Over a quarter of the world's full text scientific, technical and medical (STM) peer-reviewed articles — managed by renowned editors, written by respected authors and read by researchers from around the globe — are available in one place: ScienceDirect.

Elsevier's extensive and unique full-text collection covers authoritative titles from the core scientific literature including high impact factor titles such as THE LANCET, Cell and Tetrahedron. Over nine million articles are available online, including Articles in Press which offer online access to recently accepted manuscripts. The critical mass of trusted information available on ScienceDirect is unsurpassed. Coverage includes over 2,500 journals published by Elsevier and dynamic linking to journals from approximately 2,000 STM publishers through CrossRef. An expanding program of online major reference works, handbooks, book series and over 4,400 eBooks in all fields of science seamlessly interlinks with primary research referenced in journal articles.

About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect, MD Consult, Scopus, bibliographic databases, and online reference works.

Elsevier is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Copyright Clearance Center and the Copyright Clearance Center logo are registered trademarks of Copyright Clearance Center, Inc.